Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cross-protection by Pseudomonas aeruginosa polysaccharides.

Literature DB >> 6185423

Cross-protection by Pseudomonas aeruginosa polysaccharides.

Abstract

High-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotypes 1 and 2 gave cross-protection in outbred CD-1 mice challenged with the heterologous immunotype organism. Both active immunization with 50 micrograms of polysaccharide, as well as passive transfer of immune serum were effective. The basis for this cross-protection is the ability of high doses of polysaccharide to induce antibody formation to both homologous and heterologous immunotype determinants.

Entities: Chemical Species

Mesh：

Substances：

Year: 1982 PMID： 6185423 PMCID： PMC347865 DOI： 10.1128/iai.38.3.1117-1122.1982

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

11 in total

1. Proposal of an international standard for the infraspecific serologic classification of Pseudomonas aeruginosa.

Authors: J Y Homma; A Ghoda; S Goto; K Jo; I Kato; H Kodama; N Kosakai; M Kono; H Shionoya; Y Terada; T Tomiyama; E Yabuuchi
Journal: Jpn J Exp Med Date: 1979-02

2. Epidemiological markers for Pseudomonas aeruginosa. 1. Serogrouping, pyocine typing--and their interrelations.

Authors: T Bergan
Journal: Acta Pathol Microbiol Scand B Microbiol Immunol Date: 1973-02

3. New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

Authors: M W Fisher; H B Devlin; F J Gnabasik
Journal: J Bacteriol Date: 1969-05 Impact factor: 3.490

4. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.

Authors: J M Griffiss; B L Brandt; P L Altieri; G B Pier; S L Berman
Journal: Infect Immun Date: 1981-12 Impact factor: 3.441

5. The relationship between the O-antigenic lipopolysaccharides and serological specificity in strains of Pseudomonas aeruginosa of different O-serotypes.

Authors: I R Chester; P M Meadow; T L Pitt
Journal: J Gen Microbiol Date: 1973-10

6. Isolation and characterization of a high-molecular-weight polysaccharide from the slime of Pseudomonas aeruginosa.

Authors: G B Pier; H F Sidberry; S Zolyomi; J C Sadoff
Journal: Infect Immun Date: 1978-12 Impact factor: 3.441

7. Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors: G B Pier; H F Sidberry; J C Sadoff
Journal: Infect Immun Date: 1978-12 Impact factor: 3.441

8. Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.

Authors: G B Pier
Journal: J Clin Invest Date: 1982-02 Impact factor: 14.808

9. High-molecular-weight polysaccharide antigen from Pseudomonas aeruginosa immunotype 2.

Authors: G B Pier; H F Sidberry; J C Sadoff
Journal: Infect Immun Date: 1981-11 Impact factor: 3.441

10. Agar-Gel Precipitating Antibody in Pseudomonas aeruginosa Infections.

Authors: L S Young; B H Yu; D Armstrong
Journal: Infect Immun Date: 1970-10 Impact factor: 3.441

13 in total

1. Structural analysis and immunogenicity of Pseudomonas aeruginosa immunotype 2 high molecular weight polysaccharide.

Authors: G B Pier; S E Bennett
Journal: J Clin Invest Date: 1986-02 Impact factor: 14.808

2. Enzyme-linked immunosorbent assay antibody responses to a temperature-sensitive mutant of Pseudomonas aeruginosa.

Authors: D O Sordelli; R A Rojas; M C Cerquetti; A M Hooke; P J Degnan; J A Bellanti
Journal: Infect Immun Date: 1985-10 Impact factor: 3.441

3. Immunization with Pseudomonas aeruginosa high-molecular-weight polysaccharides prevents death from Pseudomonas burn infections in mice.

Authors: M Pollack; G B Pier; R K Prescott
Journal: Infect Immun Date: 1984-02 Impact factor: 3.441

4. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule.

Authors: K Hatano; J B Goldberg; G B Pier
Journal: J Bacteriol Date: 1993-08 Impact factor: 3.490

5. Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.

Authors: G B Pier; M Pollack; M Cohen
Journal: Infect Immun Date: 1984-08 Impact factor: 3.441

6. Further purification and characterization of high-molecular-weight polysaccharide from Pseudomonas aeruginosa.

Authors: G B Pier; M Cohen; H Jennings
Journal: Infect Immun Date: 1983-12 Impact factor: 3.441

7. Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide.

Authors: S J Cryz; E Fürer; R Germanier
Journal: Infect Immun Date: 1984-03 Impact factor: 3.441

8. In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide.

Authors: G B Pier; D Thomas; G Small; A Siadak; H Zweerink
Journal: Infect Immun Date: 1989-01 Impact factor: 3.441

9. Isolation, structure, and immunogenicity of Pseudomonas aeruginosa immunotype 4 high-molecular-weight polysaccharide.

Authors: G B Pier; M Pollack
Journal: Infect Immun Date: 1989-02 Impact factor: 3.441

10. Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody.

Authors: J F Pittet; M A Matthay; G Pier; M Grady; J P Wiener-Kronish
Journal: J Clin Invest Date: 1993-09 Impact factor: 14.808